| Parmax Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.00 | 1.90 | 0.89 | 0.94 | 1.02 |
| Long Term Debt-Equity Ratio | 0.00 | 1.75 | 0.76 | 0.85 | 0.96 |
| Current Ratio | 0.71 | 0.80 | 0.95 | 0.89 | 0.88 |
| Fixed Assets | 1.50 | 0.58 | 0.86 | 1.09 | 2.05 |
| Inventory | 9.89 | 3.30 | 4.31 | 5.37 | 7.86 |
| Debtors | 18.19 | 9.06 | 23.72 | 15.67 | 10.59 |
| Interest Cover Ratio | -1.24 | -8.13 | 1.14 | 1.77 | 4.24 |
| PBIDTM (%) | 1.06 | -30.05 | 14.85 | 14.41 | 13.44 |
| PBITM (%) | -2.59 | -45.52 | 2.66 | 3.84 | 6.03 |
| PBDTM (%) | -1.03 | -35.66 | 12.45 | 12.27 | 12.02 |
| CPM (%) | 0.04 | -36.56 | 11.54 | 11.34 | 10.27 |
| APATM (%) | -3.62 | -52.04 | -0.65 | 0.77 | 2.86 |
| ROCE (%) | 0.00 | 0.00 | 3.76 | 6.04 | 14.26 |
| RONW (%) | 0.00 | 0.00 | -1.69 | 2.38 | 13.79 |